The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The FDA approves Utebzi, boosting Spero Therapeutics, Inc. via GSK milestones and royalties. Click for more on SPRO stock and see if it is right for you.

The ZTE SPro 2 is a portable and powerful projector that runs Android, and even though the price point may seem quite steep, this device does what it is designed to do extremely well. One of the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Spero Therapeutics (NASDAQ:SPRO) shares climbed 16% on Thursday after the U.S. Food and Drug Administration approved Utebzi, a novel oral carbapenem antibiotic developed through a collaboration ...

Android is a truly unique platform and one of the clear benefits of such an operating system is that if a manufacturer wants, they can pretty much include android on anything they like. Within reason ...

The average one-year price target for Spero Therapeutics (NASDAQ:SPRO) has been revised to 7.65 / share. This is an increase of 12.50% from the prior estimate of 6.80 dated October 31, 2023. The price ...

Aloysius Low is a Senior Editor at CNET covering mobile and Asia. Based in Singapore, he loves playing Dota 2 when he can spare the time and is also the owner-minion of two adorable cats. I've ...

Spero Therapeutics Inc. Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on identifying, developing, and commercializing treatments involving bacterial infections, ...